Related Experiment Video
Updated: May 18, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition
C S Ku1, D N Cooper, B Iacopetta
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. cheeseng.ku@ki.se
Abstract:
The clinical application of next-generation sequencing (NGS) as a diagnostic tool has become increasingly evident. The coupling of NGS technologies with new genomic sequence enrichment methods has made the sequencing of panels of target genes technically feasible, at the same time as making such an approach cost-effective for diagnostic applications. In this article, we discuss recent studies that have applied NGS in the diagnostic setting in relation to hereditary cancer.

